The data shows the world's leading pharmaceutical companies in 2017 based on prescription sales and R&D spending. During that year, Pfizer's Rx sales were approx. 45.36 billion dollars, while R&D spending was approx. 7.63 billion dollars. Thus, in that year Pfizer was the biggest pharmaceutical company based on pure pharma revenue worldwide.
Pfizer (U.S.) | 45.36 | 7.63 |
Novartis (Switzerland) | 41.88 | 7.82 |
Roche (Switzerland) | 41.73 | 9.18 |
Merck & Co. (U.S.) | 35.36 | 7.56 |
Johnson & Johnson (USA) | 34.4 | 8.36 |
Sanofi (France) | 34.08 | 6.18 |
GlaxoSmithKline (UK) | 28.67 | 4.98 |
AbbVie (U.S.) | 27.74 | 4.83 |
Gilead Sciences (U.S.) | 25.66 | 4.98 |
Amgen (U.S.) | 21.8 | 3.48 |
AstraZeneca (UK) | 19.78 | 5.41 |
Bristol-Myers Squibb (U.S.) | 18.26 | 4.82 |
Eli Lilly (U.S.) | 18.53 | 4.97 |
Teva Pharmaceutical Industries (Israel) | 18.26 | 1.85 |
Bayer (Germany) | 17.54 | 3.26 |
Novo Nordisk (Denmark) | 16.97 | 2.13 |
Allergan (U.S.) | 14.91 | 1.6 |
Shire (Ireland) | 14.45 | 1.57 |
Boehringer Ingelheim (Germany) | 14.26 | 3.07 |
Takeda (Japan) | 13.58 | 2.94 |
Celgene (U.S.) | 12.93 | 3.02 |
Mylan (U.S.) | 11.45 | 0.66 |
Astellas Pharma (Japan) | 10.88 | 1.99 |
Biogen (U.S.) | 10.36 | 2.25 |
CSL (Australia) | 7.52 | 0.63 |
Daiichi Sankyo (Japan) | 7.36 | 2.13 |
Merck KGaA (Germany) | 6.88 | 1.84 |
Otsuka Holdings (Japan) | 5.32 | 1.48 |
Valeant Pharmaceuticals International (Canada) | 5.05 | 0.36 |
UCB (Belgium) | 4.63 | 1.2 |
Les Laboratoires Servier (France) | 4.57 | 1.15 |
Eisai (Japan) | 4.36 | 1.26 |
Abbott Laboratories (U.S.) | 4.29 | 0.16 |
Sun Pharmaceutical Industries (India) | 4.15 | 0.32 |
Fresenius (Germany) | 4.07 | 0.43 |
Grifols (Spain) | 3.85 | 0.33 |
Regeneron (U.S.) | 3.72 | 2.08 |
Chugai Pharmaceutical (Japan) | 3.67 | 0.79 |
Alexion Pharmaceuticals (U.S.) | 3.55 | 0.81 |
Sumitomo Dainippon Pharma (Japan) | 3.53 | 0.79 |
Endo International (Ireland) | 3.47 | 0.16 |
Mallinckrodt (Ireland) | 3.14 | 0.34 |
Menarini (Italy) | 3.07 | |
Aspen Pharmacare (South Africa) | 2.59 | |
Mitsubishi Tanabe Pharma (Japan) | 2.58 | 0.71 |
Ono Pharmaceutical (Japan) | 2.36 | 0.62 |
STADA Arzneimittel (Germany) | 2.35 | 0.08 |
Lupin (India) | 2.34 | 0.31 |
Kyowa Hakko Kirin (Japan) | 2.27 | 0.44 |
Ferring Pharmaceuticals (U.S.) | 2.24 | 0.33 |